Login
Memorial Day
Baseball
Social Media
NCAA
Israel-Hamas Conflict
Premier League
European Union
Cryptocurrency
Education
Cannes Film Festival
Inauguration
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Stylus Medicine launches with $85m to advance in vivo gene editing - Pharmaceutical Technology

Summary by Pharmaceutical-technology.com
Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
pharmaceutical-technology.compharmaceutical-technology.com

Stylus Medicine launches with $85m to advance in vivo gene editing - Pharmaceutical Technology

Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in on Wednesday, May 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical

Medical

Johnson & Johnson

Johnson & Johnson

Eli Lilly

Eli Lilly

News
For You
SearchBlindspotLocal